CHEMED CORP CHE

Healthcare SIC 8082 - Services-Home Health Care Services NAICS Health Care and Social Assistance › Ambulatory Health Care Services › Home Health Care Services derived NYSE

Chemed Corporation (the "Company" or "Chemed") was incorporated in Delaware in 1970 as a subsidiary of W.R. Grace & Co. and succeeded to the business of W.R. Grace & Co.'s Special Products Group as of April 30, 1971 and remained a subsidiary of W.R. Grace & Co. until March 10, 1982.

Chemed purchases, operates and divests subsidiaries engaged in diverse business activities for the purposes of maximizing shareholder value. The Company's day to day operating businesses are managed on a decentralized basis. There are few integrated business functions between the operating units and Chemed (such as sales, marketing or purchasing). Chemed's corporate office management participates in and is ultimately responsible for long term strategic planning, significant capital allocation decisions, investment activities, financial reporting, tax, legal and the selection of the key executives of each of the operating businesses. Since its inception, the Company has engaged in twelve significant acquisitions or divestitures of diverse business units.

Last close 512.98 2026-10-23
Market cap $6.70B 2026-06-30 share count
52-week range 365.20 - 557.00

Valuation FY2025 figures against the last close

P/S2.7x
P/E28.0x
P/FCF20.6x
EV/EBITDA16.6x
Dividend yield0.5%
Diluted EPS18.34

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $2.53B$2.43B$2.26B$1.20B$1.26B$1.33B$1.28B$1.20B$1.67B$1.58B
Cost of revenue $1.71B$1.58B$1.47B$1.37B$1.37B$1.38B$1.32B$1.23B$1.15B$1.12B
Gross profit $823.2M$854.3M$798.8M-$168.3M-$108.2M-$43.5M-$39.9M-$30.1M$516.2M$461.4M
SG&A $417.2M$424.4M$395.1M$358.7M$366.7M$330.2M$305.7M$271.2M$276.7M$243.6M
Total operating expenses $2.19B$2.06B$1.92B$1.79B$1.80B$1.69B$1.68B$1.54B$1.55B$1.40B
Operating income $338.2M$366.5M$340.6M$343.5M$343.0M$389.7M$257.4M$243.6M$113.0M$178.7M
Interest expense $1.8M$1.8M$3.1M$4.6M$1.9M$2.4M$4.5M$5.0M$4.3M$3.7M
Pre-tax income $355.8M$399.5M$350.4M$329.7M$350.3M$396.0M$261.6M$239.6M$116.9M$177.1M
Income tax $90.5M$97.5M$77.9M$80.1M$81.8M$76.5M$41.7M$34.1M$18.7M$68.3M
Net income $265.2K$302.0K$272.5K$249.6K$268.6K$319.5M$219.9M$205.5M$98.2M$108.7M
EPS, basic 18.4220.1018.1116.7217.1420.0213.7712.806.116.64
EPS, diluted 18.3419.8917.9316.5316.8519.4813.3112.235.866.48
Shares, diluted (wtd. avg.) 14.5M15.2M15.2M15.1M15.9M16.4M16.5M16.8M16.7M16.8M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $74.5M$178.3M$264.0M$74.1M$32.9M$162.7M$6.2M$4.8M$11.1M$15.3M
Receivables $182.6M$171.2M$181.5M$139.4M$137.2M$126.9M$143.8M$119.5M$113.7M$132.0M
Inventory $7.5M$8.2M$12.0M$10.3M$10.1M$7.1M$7.5M$5.7M$5.3M$5.8M
Total current assets $302.6M$394.7M$500.8M$272.6M$230.3M$329.4M$190.7M$159.8M$176.0M$169.9M
Property, plant and equipment $205.7M$200.8M$203.8M$199.7M$193.7M$187.8M$175.8M$162.0M$143.0M$121.3M
Goodwill $667.0M$666.7M$585.0M$581.3M$578.6M$578.6M$577.4M$510.6M$476.9M$472.4M
Other intangibles $82.8M$92.2M$90.3M$99.7M$108.1M$118.1M$126.4M$68.3M$54.9M$55.1M
Total assets $1.54B$1.67B$1.67B$1.44B$1.34B$1.43B$1.27B$975.5M$920.0M$880.1M
Accounts payable $64.5M$44.1M$64.0M$41.9M$73.0M$54.2M$51.1M$50.1M$48.4M$39.6M
Short-term debt ———$5.0M————$10.0M$8.8M
Total current liabilities $287.1M$285.7M$312.1M$297.2M$302.4M$299.1M$262.2M$191.7M$193.5M$171.8M
Long-term debt ———$92.5M$185.0M—$90.0M$89.2M$91.2M$100.0M
Total liabilities $558.8M$549.6M$560.2M$643.3M$719.5M$533.7M$541.7M$384.2M$379.7M$356.0M
Retained earnings $2.96B$2.72B$2.45B$2.20B$1.97B$1.72B$1.43B$1.23B$1.04B$958.1M
Total equity $979.4M$1.12B$1.11B$798.7M$623.3M$901.2M$726.6M$591.3M$540.4M$524.1M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $388.3M$417.5M$330.3M$309.9M$308.6M$489.3M$301.2M$287.1M$162.5M$135.4M
Depreciation and amortisation $64.8M$63.0M$60.9M$59.2M$59.1M$56.6M$45.2M$38.9M$35.6M$34.6M
Capital expenditure $62.8M$49.5M$56.9M$57.3M$58.7M$58.8M$53.0M$52.9M$64.3M$39.8M
Investing cash flow -$59.3M-$143.9M-$60.6M-$59.4M-$57.8M-$61.6M-$190.8M-$105.2M-$67.6M-$39.9M
Financing cash flow -$432.8M-$359.2M-$79.8M-$209.3M-$380.6M-$271.2M-$109.2M-$188.2M-$99.1M-$94.9M
Dividends paid $31.7M$27.1M$23.5M$22.0M$22.0M$21.1M$19.8M$18.7M$17.4M$16.4M
Buybacks $431.5M$361.4M$67.7M$114.5M$576.0M$175.6M$92.6M$158.9M$94.6M$102.3M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001562762-26-000052.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -1B 0 1B 2B 3B Revenue, FY2016: 1.6B Gross profit, FY2016: 461.4M Net income, FY2016: 108.7M Revenue, FY2017: 1.7B Gross profit, FY2017: 516.2M Net income, FY2017: 98.2M Revenue, FY2018: 1.2B Gross profit, FY2018: -30.1M Net income, FY2018: 205.5M Revenue, FY2019: 1.3B Gross profit, FY2019: -39.9M Net income, FY2019: 219.9M Revenue, FY2020: 1.3B Gross profit, FY2020: -43.5M Net income, FY2020: 319.5M Revenue, FY2021: 1.3B Gross profit, FY2021: -108.2M Net income, FY2021: 268.6K Revenue, FY2022: 1.2B Gross profit, FY2022: -168.3M Net income, FY2022: 249.6K Revenue, FY2023: 2.3B Gross profit, FY2023: 798.8M Net income, FY2023: 272.5K Revenue, FY2024: 2.4B Gross profit, FY2024: 854.3M Net income, FY2024: 302K Revenue, FY2025: 2.5B Gross profit, FY2025: 823.2M Net income, FY2025: 265.2K FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $1.58B $1.67B $1.20B $1.28B $1.33B $1.26B $1.20B $2.26B $2.43B $2.53B
Gross profit $461.4M $516.2M -$30.1M -$39.9M -$43.5M -$108.2M -$168.3M $798.8M $854.3M $823.2M
Net income $108.7M $98.2M $205.5M $219.9M $319.5M $268.6K $249.6K $272.5K $302.0K $265.2K

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Results announced Item 2.02
  • Results announced Item 2.02
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Shareholder vote Item 5.07

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 8082

TickerCompanyMarket capP/ERevenue growth
BTSG BrightSpring Health Services, Inc. $11.89B 69.1x 28.2%
OPCH Option Care Health, Inc. $4.90B 24.6x 13.0%
AVAH Aveanna Healthcare Holdings, Inc. $2.92B 12.7x 20.2%
ADUS Addus HomeCare Corp $2.27B 23.3x 23.2%
AHCO AdaptHealth Corp. $820.8M — -0.5%